Lilly’s COVID-19 Antibody Combination Receives Emergency Use Authorization In U.S.

(RTTNews) – The U.S. Food and Drug Administration has granted emergency use authorization to Eli Lilly and Co.’s (LLY) combination antibody therapy. The therapy is authorized for the treatment of mild to moderate COVID-19 in patients aged 12 and older who are at high risk for proRead MoreMarketsMarkets Feed